The μPharma “lab-on-a-chip” platform rapidly predicts cancer cell sensitivity to targeted therapy drugs through AI-driven ...

San Diego’s cancer research machine is slamming the panic button. Researchers and clinicians say new federal changes and delays to NIH grants are already squeezing lab budgets and putting clinical ...

Dr. Elizabeth Colston ’87 once walked through FitzRandolph Gate with a degree in Molecular Biology and a senior thesis on cancer cell research. Now, nearly four decades later, Colston is on the ...

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of ...

UT Southwestern discovery could lead to a novel approach for treating heart disease and fatty liver disease. Two researchers ...

Cuba’s government granted NBC News rare access inside the Institute of Hematology and Immunology, a research facility in the ...

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

Evommune’s role within the NYSE Composite highlights biotechnology research, clinical stage development, financial ...

Salk‑linked research maps food peptides that engage tolerance‑driving T cells — a new lead for allergy science.

Paolo Ascierto positions immunotherapy as the keystone for treating all cancers, also focusing on the scientific enhancement of internal areas. The Crom of Mercogliano, a scientific center of ...

The project's long-term goal is to identify new therapeutic strategies to target immune-metabolic pathways and prevent or ...